These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29210347)

  • 1. Visceral Leishmaniasis and HIV Co-Infection in Northwest Ethiopia: Antiretroviral Treatment and Burden of Disease among Patients Enrolled in HIV Care.
    van Griensven J; Simegn T; Endris M; Diro E
    Am J Trop Med Hyg; 2018 Feb; 98(2):486-491. PubMed ID: 29210347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
    Aderie EM; Diro E; Zachariah R; da Fonseca MS; Abongomera C; Dolamo BL; Ritmeijer K
    Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):107-116. PubMed ID: 28633331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
    Abongomera C; Diro E; Vogt F; Tsoumanis A; Mekonnen Z; Admassu H; Colebunders R; Mohammed R; Ritmeijer K; van Griensven J
    Clin Infect Dis; 2017 Oct; 65(10):1703-1710. PubMed ID: 29020196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.
    van Griensven J; van Henten S; Mengesha B; Kassa M; Adem E; Endris Seid M; Abdellati S; Asefa W; Simegn T; Debasu D; Bogale T; Gedamu Y; Van Den Bossche D; Adriaensen W; Van der Auwera G; Cnops L; Vogt F; Diro E
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007765. PubMed ID: 31593563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence estimates of human immunodeficiency virus (HIV) infection among visceral leishmaniasis infected people in Northwest Ethiopia: a systematic review and meta-analysis.
    Mohebali M; Yimam Y
    BMC Infect Dis; 2020 Mar; 20(1):214. PubMed ID: 32164607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
    Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
    BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Human Immunodeficiency Virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study.
    Alemayehu M; Wubshet M; Mesfin N; Gebayehu A
    BMC Infect Dis; 2017 Feb; 17(1):152. PubMed ID: 28212625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
    Abongomera C; Diro E; de Lima Pereira A; Buyze J; Stille K; Ahmed F; van Griensven J; Ritmeijer K
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006527. PubMed ID: 29799869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia.
    Alemayehu M; Wubshet M; Mesfin N; Tamiru A; Gebayehu A
    Health Qual Life Outcomes; 2017 Aug; 15(1):65. PubMed ID: 28851361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic High-Level Parasitemia in HIV-Infected Individuals With or Without Visceral Leishmaniasis in an Endemic Area in Northwest Ethiopia: Potential Superspreaders?
    van Griensven J; van Henten S; Kibret A; Kassa M; Beyene H; Abdellati S; de Hondt A; Adriaensen W; Vogt F; Pareyn M; Ritmeijer K; Diro E
    Clin Infect Dis; 2024 Jul; 79(1):240-246. PubMed ID: 38193647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
    Burza S; Mahajan R; Sinha PK; van Griensven J; Pandey K; Lima MA; Sanz MG; Sunyoto T; Kumar S; Mitra G; Kumar R; Verma N; Das P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3053. PubMed ID: 25101665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
    Diro E; Edwards T; Ritmeijer K; Fikre H; Abongomera C; Kibret A; Bardonneau C; Soipei P; Mutinda B; Omollo R; van Griensven J; Zijlstra EE; Wasunna M; Alves F; Alvar J; Hailu A; Alexander N; Blesson S
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007132. PubMed ID: 30789910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia.
    Hurissa Z; Gebre-Silassie S; Hailu W; Tefera T; Lalloo DG; Cuevas LE; Hailu A
    Trop Med Int Health; 2010 Jul; 15(7):848-55. PubMed ID: 20487426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia.
    Welay GM; Alene KA; Dachew BA
    Epidemiol Health; 2016; 39():e2017001. PubMed ID: 28092934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.
    Diro E; Lynen L; Mohammed R; Boelaert M; Hailu A; van Griensven J
    PLoS Negl Trop Dis; 2014 May; 8(5):e2875. PubMed ID: 24854196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
    Diro E; Ritmeijer K; Boelaert M; Alves F; Mohammed R; Abongomera C; Ravinetto R; De Crop M; Fikre H; Adera C; Colebunders R; van Loen H; Menten J; Lynen L; Hailu A; van Griensven J
    PLoS Negl Trop Dis; 2015; 9(10):e0004087. PubMed ID: 26431253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude of opportunistic diseases and their predictors among adult people living with HIV enrolled in care: national level cross sectional study, Ethiopia.
    Weldegebreal T; Ahmed I; Muhiye A; Belete S; Bekele A; Kaba M
    BMC Public Health; 2018 Jul; 18(1):820. PubMed ID: 29970047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.